Food Hypersensitivity
4
Pipeline Programs
3
Companies
5
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Monoclonal Antibody
1100%
+ 5 programs with unclassified modality
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Allergy TherapeuticsUK - West Sussex
5 programs2
2
Baked MilkPhase 21 trial
Open label peanut OITPhase 21 trial
Baked MilkPhase 11 trial
E. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3Phase 11 trial
A Registry for the Food Allergy CommunityN/A1 trial
Active Trials
+2 more trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Allergy TherapeuticsOpen label peanut OIT
Allergy TherapeuticsBaked Milk
Allergy TherapeuticsE. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3
Allergy TherapeuticsBaked Milk
Allergy TherapeuticsA Registry for the Food Allergy Community
Clinical Trials (5)
Total enrollment: 23,425 patients across 5 trials
Mechanisms of Desensitization During Peanut Oral Immunotherapy
Start: Apr 2013Est. completion: Dec 201520 patients
Phase 2Completed
Study of Milk Allergy and Tolerance in Children
Start: Aug 2008Est. completion: Nov 2014170 patients
Phase 2Completed
NCT00850668Allergy TherapeuticsE. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3
Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults
Start: Oct 2009Est. completion: Oct 201015 patients
Phase 1Completed
An Interventional Study of Milk Allergy
Start: Jun 2004Est. completion: Feb 2011220 patients
Phase 1Completed
A Registry for the Food Allergy Community
Start: Aug 2017Est. completion: Aug 202723,000 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 23,425 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.